Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results-Reference-Cited by-同舟云学术

Real-world outcomes of non-responding diabetic macular edema treated with continued anti-VEGF therapy versus early switch to dexamethasone implant: 2-year results

Published:2019-09-21 Issue:12 Volume:56 Page:1341-1350
ISSN:0940-5429
Container-title:Acta Diabetologica
language:en
Short-container-title:Acta Diabetol

Author:

Busch Catharina^ORCID, ,Fraser-Bell Samantha,Iglicki Matias,Lupidi Marco,Couturier Aude,Chaikitmongkol Voraporn,Giancipoli Ermete,Rodríguez-Valdés Patricio J.,Gabrielle Pierre-Henry,Laíns Inês,Santos Ana Rita,Cebeci Zafer,Amphornphruet Atchara,Degenhardt Valentin,Unterlauft Jan-Darius,Cagini Carlo,Mané-Tauty Valérie,D’Amico Ricci Giuseppe,Hindi Isaac,Agrawal Kushal,Chhablani Jay,Loewenstein Anat,Zur Dinah,Rehak Matus

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00592-019-01416-4.pdf

Reference17 articles.

1. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al (2018) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 138:271–281

2. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T et al (2012) Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 35(3):556–564

3. Schmidt-Erfurth U, Garcia-Arumi J, Bandello F, Berg K, Chakravarthy U, Gerendas BS et al. (2017) Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA). Ophthalmologica 237(4):185–222. https://doi.org/10.1159/000458539

4. Gonzalez VH, Campbell J, Holekamp NM, Kiss S, Loewenstein A, Augustin AJ et al (2016) Early and long-term responses to anti-vascular endothelial growth factor therapy in diabetic macular edema: analysis of protocol I Data. Am J Ophthalmol 172:72–79

5. Bressler NM, Beaulieu WT, Maguire MG, Glassman AR, Blinder KJ, Bressler SB et al (2018) Early response to anti-vascular endothelial growth factor and two-year outcomes among eyes with diabetic macular edema in protocol T. Am J Ophthalmol 195:93–100

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Outcomes of a Loading Phase with Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration (n-AMD) and Diabetic Macular Edema (DME);Ophthalmology and Therapy;2024-06-04

2. Switching to an Intravitreal Dexamethasone Implant after Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema: A Review;Life;2024-06-03

3. Influence of prior treatment protocol on intravitreal dexamethasone implant behavior in patients with diabetic macular edema in real-world practice;Expert Opinion on Drug Safety;2024-01-17

4. Optical coherence tomography in the management of diabetic macular oedema;Progress in Retinal and Eye Research;2024-01

5. Oct biomarkers for early prognosis in diabetic macular edema treatment with ranibizumab;European Journal of Ophthalmology;2023-11-03